During the past decade, Gazi University Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 6 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 5 clinical trials were completed. i.e. 31.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gazi University Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 8 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Incyte Corporation" with 3 trials sponsored, "Swedish Orphan Biovitrum" with 2 trials sponsored and "Amicus Therapeutics" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gazi University Hospital" #1 collaborator was "Central European Myeloma Study Group" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator, "European Myeloma Network" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Gazi University Hospital" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Myelofibrosis" (2 trials), "Post Essential Thrombocythemia Myelofibrosis" (2 trials), "Post Polycythemia Vera Myelofibrosis" (2 trials) and "Primary Myelofibrosis" (2 trials). Many other conditions were trialed in "Gazi University Hospital" in a lesser frequency.

Most popular intervention types in "Gazi University Hospital" are "Drug" (22 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amivantamab" (4 trials), "Placebo" (4 trials), "Lazertinib" (3 trials), "Atezolizumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Gazi University Hospital" are 24 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Gazi University Hospital". undefined are not yet recruiting, 9 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Gazi University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gazi University Hospital, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Gazi University Hospital has several departments that took part in Clinical trials: "Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Clinic" - 9 trials